Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

451 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Defining persistent Staphylococcus aureus bacteraemia: secondary analysis of a prospective cohort study.
Kuehl R, Morata L, Boeing C, Subirana I, Seifert H, Rieg S, Kern WV, Kim HB, Kim ES, Liao CH, Tilley R, Lopez-Cortés LE, Llewelyn MJ, Fowler VG, Thwaites G, Cisneros JM, Scarborough M, Nsutebu E, Gurgui Ferrer M, Pérez JL, Barlow G, Hopkins S, Ternavasio-de la Vega HG, Török ME, Wilson P, Kaasch AJ, Soriano A; International Staphylococcus aureus collaboration study group and the ESCMID Study Group for Bloodstream Infections, Endocarditis and Sepsis. Kuehl R, et al. Among authors: perez jl. Lancet Infect Dis. 2020 Dec;20(12):1409-1417. doi: 10.1016/S1473-3099(20)30447-3. Epub 2020 Aug 4. Lancet Infect Dis. 2020. PMID: 32763194
18F-FDG PET/CT in the diagnosis of prosthetic valve endocarditis.
Vidal V, Albiach C, Gradolí J, Pérez JL, Montagud V, Belchí J, Morell S, Fácila L. Vidal V, et al. Among authors: perez jl. Rev Port Cardiol (Engl Ed). 2018 Aug;37(8):717.e1-717.e5. doi: 10.1016/j.repc.2017.05.014. Epub 2018 Jun 19. Rev Port Cardiol (Engl Ed). 2018. PMID: 29934214 Free article. English, Portuguese.
Author Correction: BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans.
Şahin U, Muik A, Vogler I, Derhovanessian E, Kranz LM, Vormehr M, Quandt J, Bidmon N, Ulges A, Baum A, Pascal KE, Maurus D, Brachtendorf S, Lörks V, Sikorski J, Koch P, Hilker R, Becker D, Eller AK, Grützner J, Tonigold M, Boesler C, Rosenbaum C, Heesen L, Kühnle MC, Poran A, Dong JZ, Luxemburger U, Kemmer-Brück A, Langer D, Bexon M, Bolte S, Palanche T, Schultz A, Baumann S, Mahiny AJ, Boros G, Reinholz J, Szabó GT, Karikó K, Shi PY, Fontes-Garfias C, Perez JL, Cutler M, Cooper D, Kyratsous CA, Dormitzer PR, Jansen KU, Türeci Ö. Şahin U, et al. Among authors: perez jl. Nature. 2025 Jul;643(8074):E27. doi: 10.1038/s41586-025-09355-7. Nature. 2025. PMID: 40670800 No abstract available.
First year after surgery is the optimal period to define early prosthetic valve endocarditis: a cohort study.
Calderón-Parra J, Escrihuela F, Cuervo G, López-Azor JC, Muñoz P, Machado M, Marín M, Rodríguez-Esteban MÁ, Rodríguez-García R, Gutiérrez F, Miró Meda JM, Goenaga MÁ, Goikoetxea-Agirre J, de Alarcón A, Vidal-Bonnet L, Ramos-Martinez A; GAMES Investigators. Calderón-Parra J, et al. Open Heart. 2025 Jun 26;12(1):e003378. doi: 10.1136/openhrt-2025-003378. Open Heart. 2025. PMID: 40571490 Free PMC article.
Helicity-Dependent Enzymatic Peptide Cyclization.
Durukan C, Faierson J, van der Wal I, Pérez JL, Hennig S, Grossmann TN. Durukan C, et al. Among authors: perez jl. J Pept Sci. 2025 Jun;31(6):e70024. doi: 10.1002/psc.70024. J Pept Sci. 2025. PMID: 40289331 Free PMC article.
Body mass index and prognosis of infective endocarditis.
Frías-García R, Muñoz García P, Machado Vilchez M, Cuerpo Caballero G, Rodríguez-García R, Rodríguez-Esteban MÁ, Fariñas-Álvarez MC, Miró Meda JM, Gutiérrez Villanueva A, Ojeda-Burgos G, Goikoetxea-Agirre AJ, Bernal Palacios M, Martínez-Sellés M; Spanish Collaboration on Endocarditis-Grupo de Apoyo al Manejo de la Endocarditis Infecciosa en España (GAMES); Spanish Collaboration on Endocarditis-Grupo de Apoyo al Manejo de la Endocarditis Infecciosaen España (GAMES). Frías-García R, et al. Infect Dis (Lond). 2025 Aug;57(8):793-800. doi: 10.1080/23744235.2025.2481914. Epub 2025 Apr 1. Infect Dis (Lond). 2025. PMID: 40169014
Impact of SARS-CoV-2 infection therapies on the risk of venous thromboembolism and cardiovascular events from the SEMI-COVID-19 Registry.
Oblitas CM, Demelo-Rodríguez P, Barrera-López L, Galeano-Valle F, Rubio-Rivas M, Luque Del Pino J, Giner Galvañ V, Paredes-Ruíz D, Fernández-Madera Martínez R, Gericó Aseguinolaza M, Gómez-Huelgas R, Fernández FA, Torres Peña JD, Martín González JI, Méndez-Bailón M, Monge Monge D, Freire Castro SJ, Pastor Valverde C, Rodilla-Sala E, Guzmán García M, Rivas-Carmenado M, Gallo CM, Perea Ribis MA, Casas-Rojo JM, Millán Núñez-Cortés J; SEMICOVID-19 Network. Oblitas CM, et al. Sci Rep. 2025 Mar 5;15(1):7722. doi: 10.1038/s41598-025-90278-8. Sci Rep. 2025. PMID: 40044746 Free PMC article.
Efficacy and safety of sipavibart for prevention of COVID-19 in individuals who are immunocompromised (SUPERNOVA): a randomised, controlled, double-blind, phase 3 trial.
Haidar G, Thomas S, Loubet P, Baker RI, Benfield T, Boonyaratanakornkit J, Kiertiburanakul S, Kim AHJ, Longbrake EE, Molina JM, Paredes R, Tucker D, Uriel A, Weinmann-Menke J, Aksyuk AA, Clegg LE, Currie A, Yang H, Flyrin K, Gibbs M, Shroff M, Perez JL, Chang LJ, Cohen TS; SUPERNOVA study group. Haidar G, et al. Among authors: perez jl. Lancet Infect Dis. 2025 Jul;25(7):813-826. doi: 10.1016/S1473-3099(24)00804-1. Epub 2025 Feb 24. Lancet Infect Dis. 2025. PMID: 40015292 Clinical Trial.
451 results